Literature DB >> 31277188

Mediterranean dietary pattern and the risk of prostate cancer: A meta-analysis.

Sheng Cheng1, Qiming Zheng, Guoqing Ding, Gonghui Li.   

Abstract

BACKGROUND: Mediterranean dietary pattern has attracted great attention in terms of its effect on human health. However, whether Mediterranean dietary pattern is an independent protective factor for prostate cancer remains controversial. Our goal was to evaluate this association by conducting a meta-analysis of observational studies.
METHODS: We searched the PubMed and EMBASE database through February 2019 for relevant studies that examined the association between Mediterranean Diet and prostate cancer risk. The combined risk estimates were computed using a DerSimonian random-effects model.
RESULTS: A total of 10 eligible studies were included in this meta-analysis. The pooled risk estimates and 95% confidence interval (CI) in relation to Mediterranean diet pattern were 0.95 (95% CI: 0.90 to 1.01) for total prostate cancer, 0.93 (95% CI: 0.75 to 1.14) for advanced prostate cancer, 0.96 (95% CI: 0.81 to 1.14) for localized prostate cancer, and 0.92 (95% CI: 0.76 to 1.11) for fatal prostate cancer. There was no evidence of heterogeneity for total (P = .326, I = 12.7%), localized (P = .706, I = 0.0%) and fatal prostate cancer (P = .282, I = 13.0%), but not for advanced prostate cancer (P = .018, I = 63.4%).
CONCLUSION: This large meta-analysis of observational studies suggests that Mediterranean dietary pattern has no relationship with prostate cancer risk.

Entities:  

Mesh:

Year:  2019        PMID: 31277188      PMCID: PMC6635247          DOI: 10.1097/MD.0000000000016341

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


Introduction

Prostate cancer is the second most common cancer in men worldwide with approximately 220,000 newly diagnosed cases and 27,500 patient deaths annually in the United States.[ In China, there were about 60,300 newly diagnosed cases and 26,600 patient deaths from prostate cancer in 2015.[ Although localized prostate cancer has a favorable prognosis, the 5-year survival rate drops to less than 30% for patients with advanced metastatic tumors.[ Age, race, and family history of prostate cancer are the only well-established risk factors for prostate cancer.[ Therefore, it is urgent to further reveal other risk and protective factors to improve the prevention of prostate cancer. Mediterranean dietary pattern has attracted great attention in terms of its effect on human health. Mediterranean diet encourage consumption of vegetables and fruits, nuts and seeds, whole grains, dairy products, olive oil, fish, and fresh seafood, while restricted intake of red meat and processed, fatty and sugary foods.[ Jones et al[ reported that a high adherence to the Mediterranean dietary pattern is significantly associated with a lower risk of colorectal cancer, especially rectal cancer in UK Women's Cohort Study. Witlox et al[ found an inverse association between the Mediterranean diet and bladder cancer risk based on a pooled analysis of 13 cohort studies. Hodge et al[ suggested that adherence to Mediterranean dietary pattern was significantly inversely associated with lung cancer risk in the Melbourne Collaborative Cohort Study. It also has been hypothesized that Mediterranean dietary pattern may reduce the risk of future prostate cancer events. In the past few years, there is a rapidly growing interest in testing this hypothesis. Many epidemiologic studies have examined the association between Mediterranean diet and the risk of prostate cancer, and most found a negative but not significant association possibly due to the limited power in individual studies.[ A better understanding of this issue may have potential important public health and clinical implications as widely recommendation of Mediterranean dietary pattern possibly reduce the incidence of prostate cancer. Therefore, the aim of our study was to evaluate the association between Mediterranean diet and the risk of total prostate cancer, advanced prostate cancer, localized prostate cancer, and fatal prostate cancer by performing a meta-analysis of observational studies.

Methods

Search strategy

We reported this meta-analysis according to the PRISMA guidelines.[ We searched the PubMed and EMBASE database through February 2019 for relevant studies that examined the association between Mediterranean dietary pattern and prostate cancer risk. The following search terms were used: Mediterranean diet, Mediterranean, MD score, dietary pattern, Mediterranean diet score, dietary score, and dietary adherence; and prostate cancer and prostate neoplasm. No restrictions on publication date or language were imposed. In addition, we checked the reference lists of retrieved articles and reviews for additional potentially relevant studies. This is a systematic review and meta-analysis, which was based on previous published studies and did not have original data. Therefore, no ethical approval and patient consent are required.

Study selection

We firstly performed an initial screening of titles and/or abstracts to exclude obviously irrelevant studies. Then a second screening of full-text article was performed. Included studies met the following criteria: It was an observational study, including cohort, nested case-control, case-cohort, or case-control study; the exposure of interest was Mediterranean dietary pattern; the outcome of interest was prostate cancer risk; and risk estimates and the corresponding 95% confidence interval (CI) (or data to calculate them) were available.

Data extraction

Data extraction was performed using a standardized data-collection form with pre-defined variables. We extracted any reported relative risks (RRs), hazard ratios (HRs), odds ratios (ORs), or incidence density ratios of outcomes for participants with highest Mediterranean diet score compared with the lowest group. We also extracted the following study characteristics: first author's surname; publication year; country of origin; study design; study name of source; period of follow-up for cohort studies; age of study population; number of prostate cancer cases and controls/total participants; ascertainments of Mediterranean diet; assessments of outcomes; and statistical adjustments for confounding factors. Two authors (SC and GL) independently performed the studies selection and data extraction. Any disagreements were resolved by consensus.

Statistical analyses

RR was used as a summary effect size estimate of the association between Mediterranean diet pattern and the risk of prostate cancer across studies. Because prostate cancer was a rare disease, the HRs and ORs were directly considered as RRs. The combined risk estimates were computed using a DerSimonian random-effects model.[ Homogeneity of RRs across studies was examined using the Q statistic (significance level at P < .10). The I2 statistic was also calculated to quantitatively measure the inconsistency across studies.[ Because study design, sample size, and ascertainment of Mediterranean diet pattern were not consistent across studies, we further performed various subgroup analyses to explore possible explanations for heterogeneity. We also examined the influence of a single study on the overall risk estimate by repeating meta-analysis after omitting one study in each turn. Potential publication bias was firstly assessed by visual inspection of a funnel plot in which the log RR was plotted against its SE. We also performed the Begg rank correlation test[ and Egger linear regression test[ to examine the publication bias. The subgroup analysis, sensitivity analysis, and publication analysis were only performed for total prostate cancer risk because of rather small numbers of studies for other outcomes. All analyses were performed using STATA version 11.0 (StataCorp LP, College Station, TX). The P < .05 was considered statistically significant, except where otherwise specified.

Results

Literature search

We initially retrieved 338 unique citations from the PubMed and EMBASE database. Of these, the majority were excluded after the first screening of abstracts and/or titles, mainly because they were reviews, non-human studies, or obviously not relevant to our analysis. After full-text review of 18 articles, 8 studies were excluded because of the following reasons: lack of exposure information (n = 3), lack of outcome information (n = 4), and lack of risk estimates (n = 1). Finally, 10 studies[ were included in this meta-analysis. A flow chart showing the process of study selection is presented in Figure 1.
Figure 1

Flow diagram of literature search process.

Flow diagram of literature search process.

Study characteristics

The main characteristics of the 10 observational studies, including 5 cohort and 5 case-control studies, are presented in Table 1. These studies were published between 2009 and 2018. Two studies were performed in the United States, 5 in Europe, 2 in Iran, and 1 in Australia. The number of prostate cancer cases ranged from 52 to 23,453 (total 33,451). The ascertainment of Mediterranean diet pattern varied across studies, with most based on self-report or interviewer-administered questionnaires. All 10 studies reported total prostate cancer risk in relation to Mediterranean diet pattern, 6 reported advanced prostate cancer, 3 reported localized prostate cancer, and 2 reported fatal prostate cancer. Outcome assessments were based on a variety of sources, including medical records, cancer register, and hospital database. NOS score ranged from 6 to 9 with a mean value of 7.4 (Supplementary Table S1).
Table 1

Main characteristic of included studies.

Main characteristic of included studies.

Mediterranean diet pattern and the risk of total prostate cancer

Figure 2 shows the results from the random-effects model combining the RRs for total prostate cancer. Among the 10 studies, 8 showed a negative relation between Mediterranean diet pattern and the risk of total prostate cancer but only 2 have a statistically significant effect. The RRs for the association varied from 0.28 to 1.04 across studies. Overall, there was no significant association between Mediterranean diet pattern and the risk of total prostate cancer (RR: 0.95 [95% CI: 0.90 to 1.01]). No obvious heterogeneity was observed (P = .326, I2 = 12.7%).
Figure 2

A forest plot of relative risk for total prostate cancer in relation to Mediterranean dietary pattern.

A forest plot of relative risk for total prostate cancer in relation to Mediterranean dietary pattern.

Mediterranean diet pattern and the risk of advanced, localized, and fatal prostate cancer

Although there were fewer studies for these outcomes than total prostate cancer, the results were relatively consistent. The pooled RRs in relation to Mediterranean diet pattern were 0.93 (95% CI: 0.75 to 1.14) for advanced prostate cancer (Fig. 3), 0.96 (95% CI: 0.81 to 1.14) for localized prostate cancer, and 0.92 (95% CI: 0.76 to 1.11) for fatal prostate cancer. There was no evidence of heterogeneity for localized (P = .706, I2 = 0.0%) and fatal prostate cancer (P = .282, I2 = 13.0%), but not for advanced prostate cancer (P = .018, I2 = 63.4%).
Figure 3

A forest plot of relative risk for advanced prostate cancer in relation to Mediterranean dietary pattern.

A forest plot of relative risk for advanced prostate cancer in relation to Mediterranean dietary pattern.

Subgroup analysis and sensitivity analyses

In subgroup analyses, none of the following factors modified the association between Mediterranean diet pattern and the risk of total prostate cancer: geographic area, study design, number of cases, method of exposure assessment, and publication year (Table 2, all P for interaction >.05). Further exclusion of any single study did not materially alter the pooled RR, with a range from 0.93 (95% CI: 0.84 to 1.04) to 0.96 (95% CI: 0.92 to 1.00) (Fig. 4).
Table 2

Subgroup analysis of the association between Mediterranean dietary pattern and total prostate cancer risk.

Figure 4

Sensitivity analysis was performed by excluding each study in turn.

Subgroup analysis of the association between Mediterranean dietary pattern and total prostate cancer risk. Sensitivity analysis was performed by excluding each study in turn.

Publication bias

Visual inspection of a funnel plot identified a certain degree of asymmetry (Fig. 5). The Begg rank correlation test also indicated that there was some evidence of publication bias among studies of Mediterranean diet pattern in relation to the risk of total prostate cancer (Begg, P = .049; Egger, P = .770).
Figure 5

A funnel plot for publication bias.

A funnel plot for publication bias.

Discussion

There is rapidly growing interest in the association between Mediterranean dietary pattern and health outcome. Our meta-analysis of 10 eligible epidemiological studies provides evidence that Mediterranean Diet is not related with the risk of total, advanced, localized, or fatal prostate cancer. The results of our study were not completely in agreement with a recent meta-analysis on the same topic. This systematic review published in 2017 by Schwingshackl et al[ investigated the effects of adherence to Mediterranean Diet on the risk of various types of cancer. They found a borderline statistically significant association of Mediterranean Diet with prostate cancer risk based on 6 studies (RR: 0.96, 95% CI 0.92 to 1.00). By contrast, our meta-analysis included more relevant studies (a total of 10 studies) and thus had larger sample size, which provided a more firm conclusion. The potential protective effect of Mediterranean dietary pattern on the risk of prostate cancer has some theoretical basis. The main component of the Mediterranean Diet is olive oil, which has protective effects against cancer due to oleic acid, the main MUFA in olive oil.[ In addition, Mediterranean Diet also has high consumption of tomato sauce. A previous large meta-analysis included a total of 24 published studies with 15,099 cases and indicated that tomato intake was associated with a reduced risk of prostate cancer (RR 0.86, 95% CI 0.75–0.98, P = .019).[ Therefore, Mediterranean Diet represents a healthy dietary pattern in the context of a healthy lifestyle habits.[ By contrast, an unhealthy dietary pattern, Western Diet, significantly increased the risk of prostate cancer.[ However, the results of this large meta-analysis failed to reveal a protective effect of Mediterranean Diet on prostate cancer risk. Our study had some limitations. First, the inclusion of case-control studies had the possibility of reverse causation and selection bias. Therefore, we have performed subgroup analysis by study design (case-control vs cohort studies) and the results were consistent. Second, some evidence of publication bias was observed using funnel plot and Begg test. Although we comprehensively searched the PubMed and EMBASE database, grey literature, such as conference abstract, dissertations, committee reports, and so on, was less likely to be found.[ Third, the eligible studies for some outcomes were few and thus additional studies are required to reach a definitive conclusion. Finally, the definition of Mediterranean dietary pattern and cutoff points varied across studies, which possibly introduced some misclassification bias. The bias can either be away from or towards the null hypothesis.[ Our study also had some strength. A major strength of our study is that the low heterogeneity across studies. Moreover, sensitivity analyses and subgroup analyses based on various study characteristics do not change the direction of the association between Mediterranean dietary pattern and the risk of total prostate cancer. Finally, using an enlarged sample size of 33,451 cases, we have enhanced statistical power to provide more precise and reliable risk estimates.

Conclusion

This large meta-analysis of observational studies suggests that Mediterranean dietary pattern has no relationship with prostate cancer risk.

Author contributions

Conceptualization: Sheng Cheng, Qiming Zheng, Guoqing Ding, Gonghui Li. Data curation: Sheng Cheng, Qiming Zheng, Guoqing Ding, Gonghui Li. Formal analysis: Sheng Cheng, Guoqing Ding, Gonghui Li. Funding acquisition: Sheng Cheng, Guoqing Ding, Gonghui Li. Investigation: Sheng Cheng, Gonghui Li. Methodology: Sheng Cheng, Qiming Zheng, Guoqing Ding, Gonghui Li. Project administration: Sheng Cheng, Gonghui Li. Resources: Sheng Cheng, Qiming Zheng, Guoqing Ding, Gonghui Li. Software: Sheng Cheng, Guoqing Ding, Gonghui Li. Supervision: Sheng Cheng, Qiming Zheng, Guoqing Ding, Gonghui Li. Validation: Sheng Cheng, Gonghui Li. Visualization: Sheng Cheng, Qiming Zheng, Gonghui Li. Writing – original draft: Sheng Cheng, Qiming Zheng, Guoqing Ding, Gonghui Li. Writing – review & editing: Sheng Cheng, Gonghui Li.
  5 in total

Review 1.  Dietary Factors and Prostate Cancer Development, Progression, and Reduction.

Authors:  Michał Oczkowski; Katarzyna Dziendzikowska; Anna Pasternak-Winiarska; Dariusz Włodarek; Joanna Gromadzka-Ostrowska
Journal:  Nutrients       Date:  2021-02-03       Impact factor: 5.717

Review 2.  Dietary Factors and Supplements Influencing Prostate Specific-Antigen (PSA) Concentrations in Men with Prostate Cancer and Increased Cancer Risk: An Evidence Analysis Review Based on Randomized Controlled Trials.

Authors:  Maria G Grammatikopoulou; Konstantinos Gkiouras; Stefanos Τ Papageorgiou; Ioannis Myrogiannis; Ioannis Mykoniatis; Theodora Papamitsou; Dimitrios P Bogdanos; Dimitrios G Goulis
Journal:  Nutrients       Date:  2020-09-29       Impact factor: 5.717

3.  Dietary patterns and risk of bladder cancer: a systematic review and meta-analysis.

Authors:  Mostafa Dianatinasab; Elaheh Forozani; Ali Akbari; Nazanin Azmi; Dariush Bastam; Mohammad Fararouei; Anke Wesselius; Maurice P Zeegres
Journal:  BMC Public Health       Date:  2022-01-11       Impact factor: 3.295

4.  Narrative review of Mediterranean diet in Cilento: longevity and potential prevention for prostate cancer.

Authors:  Matteo Ferro; Giuseppe Lucarelli; Carlo Buonerba; Daniela Terracciano; Giovanni Boccia; Giuseppe Cerullo; Vincenzo Cosimato
Journal:  Ther Adv Urol       Date:  2021-07-22

Review 5.  Impact of lifestyle in prostate cancer patients. What should we do?

Authors:  Herney Andrés García-Perdomo; Juan Camilo Gómez-Ospina; María Juliana Chaves-Medina; Jesús Moreno Sierra; Ana María Autrán Gómez; Juan Gómez Rivas
Journal:  Int Braz J Urol       Date:  2022 Mar-Apr       Impact factor: 1.541

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.